share_log
Benzinga ·  04/30 09:19

NRx Pharmaceuticals Shares Are Trading Lower After the Company Announced Findings From Its Phase 2b/3 Trial of NRX-101 Vs. Lurasidone

nRx Pharmicals公佈了其 NRX-101 Vs. 2b/3階段試驗的結果後,該公司股價走低盧拉西酮

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論